Civic Intelligence

Peptide Therapeutics Foundation

990EZ • Fiscal year 2013 • EIN 26-3728931

Jan 01, 2013 to Dec 31, 2013 • Filed on Jul 17, 2014

4245 Sorrento Valley Blvd92121

(858) 657-1511

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

79th percentile

0.15x

Higher debt load relative to assets than 79% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Liabilities / Revenue

91st percentile

0.38x

Higher debt load relative to revenue than 91% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Net Margin

74th percentile

17%

Higher net margin than 74% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Top Officer Pay

73rd percentile

$0

Higher top officer pay than 73% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Assets

$321,273

No earlier filing loaded for comparison.

Net Assets

$274,195

No earlier filing loaded for comparison.

Liabilities

$47,078

No earlier filing loaded for comparison.

Revenue

$122,329

No earlier filing loaded for comparison.

Expenses

$101,707

No earlier filing loaded for comparison.

Net Income

$20,622

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0Assets 2013: $321,273Liabilities 2013: $47,078Net Assets 2013: $274,1952013Assets 2014: $348,771Liabilities 2014: $49,919Net Assets 2014: $298,8522014Assets 2015: $389,214Liabilities 2015: $58,059Net Assets 2015: $331,1552015Assets 2016: $404,349Liabilities 2016: $58,620Net Assets 2016: $345,7292016Assets 2017: $478,564Liabilities 2017: $67,800Net Assets 2017: $410,7642017Assets 2018: $433,418Liabilities 2018: $1,296Net Assets 2018: $432,1222018Assets 2019: $442,929Liabilities 2019: $431Net Assets 2019: $442,4982019Assets 2020: $442,709Liabilities 2020: $2,807Net Assets 2020: $439,9022020Assets 2021: $373,700Liabilities 2021: $197Net Assets 2021: $373,5032021Assets 2022: $281,743Liabilities 2022: $500Net Assets 2022: $281,2432022Assets 2023: $286,944Net Assets 2023: $286,9442023Assets 2024: $335,263Net Assets 2024: $335,2632024

Highlighted filing

2013

Assets$321,273
Liabilities$47,078
Net Assets$274,195

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2013: $122,329Expenses 2013: $101,707Net Income 2013: $20,6222013Revenue 2014: $137,675Expenses 2014: $113,018Net Income 2014: $24,6572014Revenue 2015: $142,758Expenses 2015: $110,455Net Income 2015: $32,3032015Revenue 2016: $136,200Expenses 2016: $121,626Net Income 2016: $14,5742016Revenue 2017: $172,574Expenses 2017: $107,539Net Income 2017: $65,0352017Revenue 2018: $127,978Expenses 2018: $106,620Net Income 2018: $21,3582018Revenue 2019: $121,265Expenses 2019: $110,889Net Income 2019: $10,3762019Revenue 2020: $43,680Expenses 2020: $46,276Net Income 2020: -$2,5962020Revenue 2021: $66,103Expenses 2021: $115,909Net Income 2021: -$49,8062021Revenue 2022: $110,022Expenses 2022: $129,463Net Income 2022: -$19,4412022Revenue 2023: $134,883Expenses 2023: $157,903Net Income 2023: -$23,0202023Revenue 2024: $174,477Expenses 2024: $144,680Net Income 2024: $29,7972024

Highlighted filing

2013

Revenue$122,329
Expenses$101,707
Net Income$20,622
Jump To
Filing Snapshot
Filing Period
Jan 1, 2013 to Dec 31, 2013
Signed
Jul 17, 2014
Return Version
2013v3.0
Gross Receipts
$122,329
Mission and Program Overview

Mission

The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.

Program Services

DescriptionGrantsExpenses
HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOPMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 33 FREE POSTDOCTORAL FELLOWS WITH FREE REGISTRATION TO THE SYMPOSIUM.$0$94,021
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
SOUMITRA GHOSHPresident-$0--
TORSTEN HOFFMANNBoard Member-$0--
RICHARD DIMARCHIChairman-$0--
ADRIENNE DAYSecretary & Treasurer-$0--
RODNEY LAXBoard Member-$0--
JESSE DONGBoard Member-$0--
HANS-JOACHIM BOHMBoard Member-$0--
PANKAJ PATELBoard Member-$0--
CLAUDIO SCHTEINGARTBoard Member-$0--
Filing and Contact Details

Filer

EIN
26-3728931
Phone
8586571511

Signing Officer

Name
Adrienne Day
Title
Treasurer
Phone
8586571511
Signed
2014-07-17
Discuss with paid preparer
Yes

Preparer

Preparer
Marshall Varano
Phone
8585352000
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 8 - Other Revenue

Description: other revenue. Amount: 2,013.

Form 990-ez, Part I, Line 16 - Other Expenses

Description: symposium expenses. Amount: 94,021. Description: board expenses. Amount: 2,005. Description: board maintenance. Amount: 2,394. Description: miscellaneous. Amount: 527. Total to form 990-ez, line 16: 98,947.

Form 990-ez, Part II, Line 24 - Other Assets

Description: amylin contribution receivable. Beg. Of year amount: 20,000. End of year amount: 0.

Form 990-ez, Part II, Line 26 - Other Liabilities

Description: accrued symposium expense. Beg. Of year amount: 37,582. End of year amount: 47,078. Description: accrued travel expense. Beg. Of year amount: 2,013. End of year amount: 0.

Raw XML Appendix203 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine10THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum08586571511
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine104245 SORRENTO VALLEY BLVD
IRS990EZ/BooksInCareOfDetail/USAddress/City0SAN DIEGO
IRS990EZ/BooksInCareOfDetail/USAddress/State0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCode092121
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0273168
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0321273
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt077440
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt020622
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt02760
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0293168
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0321273
IRS990EZ/GrossReceiptsAmt0122329
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0253573
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0274195
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0253573
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0274195
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt00.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt32.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt50.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt60.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt70.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt80.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0SOUMITRA GHOSH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1TORSTEN HOFFMANN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2RICHARD DIMARCHI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3ADRIENNE DAY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4RODNEY LAX
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5JESSE DONG
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6HANS-JOACHIM BOHM
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7PANKAJ PATEL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm8CLAUDIO SCHTEINGART
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2CHAIRMAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SECRETARY & TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt8BOARD MEMBER
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt020000
IRS990EZ/OtherAssetsTotalDetail/EOYAmt00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt098947
IRS990EZ/OtherRevenueTotalAmt02013
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.
IRS990EZ/ProgramServiceRevenueAmt042876
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOPMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 33 FREE POSTDOCTORAL FELLOWS WITH FREE REGISTRATION TO THE SYMPOSIUM.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt094021
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt039595
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt047078
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt0101707
IRS990EZ/TotalProgramServiceExpensesAmt094021
IRS990EZ/TotalRevenueAmt0122329
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.PEPTIDETHERAPEUTICS.ORG
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt077440
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0114970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0139970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt090000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt085000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0507380
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt042876
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt052819
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt057090
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt057763
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt048031
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0258579
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearAmt02013
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus4YearsAmt010435
IRS990ScheduleA/OtherIncome509Grp/TotalAmt012448
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.98400
IRS990ScheduleA/PublicSupportPY509Pct00.98740
IRS990ScheduleA/PublicSupportTotal509Amt0765959
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt00
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0120316
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0167789
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0197060
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0147763
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0133031
IRS990ScheduleA/Total509Grp/TotalAmt0765959
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0122329
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0167789
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0197060
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0147763
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0143466
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0778407
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: OTHER REVENUE. AMOUNT: 2,013.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DESCRIPTION: SYMPOSIUM EXPENSES. AMOUNT: 94,021. DESCRIPTION: BOARD EXPENSES. AMOUNT: 2,005. DESCRIPTION: BOARD MAINTENANCE. AMOUNT: 2,394. DESCRIPTION: MISCELLANEOUS. AMOUNT: 527. TOTAL TO FORM 990-EZ, LINE 16: 98,947.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2DESCRIPTION: AMYLIN CONTRIBUTION RECEIVABLE. BEG. OF YEAR AMOUNT: 20,000. END OF YEAR AMOUNT: 0.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3DESCRIPTION: ACCRUED SYMPOSIUM EXPENSE. BEG. OF YEAR AMOUNT: 37,582. END OF YEAR AMOUNT: 47,078. DESCRIPTION: ACCRUED TRAVEL EXPENSE. BEG. OF YEAR AMOUNT: 2,013. END OF YEAR AMOUNT: 0.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 8 - OTHER REVENUE
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02015-11-30 17:44:51Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ADRIENNE DAY
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum08586571511
ReturnHeader/BusinessOfficerGrp/SignatureDt02014-07-17
ReturnHeader/Filer/BusinessName/BusinessNameLine10PEPTIDE THERAPEUTICS FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0PEPT
ReturnHeader/Filer/EIN0263728931
ReturnHeader/Filer/PhoneNum08586571511
ReturnHeader/Filer/USAddress/AddressLine104245 SORRENTO VALLEY BLVD
ReturnHeader/Filer/USAddress/City0SAN DIEGO
ReturnHeader/Filer/USAddress/State0CA
ReturnHeader/Filer/USAddress/ZIPCode092121
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0221478099
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine10COHNREZNICK LLP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine109255 TOWNE CENTRE DRIVE - SUITE 250
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/City0SAN DIEGO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/State0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCode092121
ReturnHeader/PreparerPersonGrp/PhoneNum08585352000
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0MARSHALL VARANO
ReturnHeader/ReturnTs02014-07-18T12:08:23-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02013-01-01
ReturnHeader/TaxPeriodEndDt02013-12-31
ReturnHeader/TaxYr02013

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings